iTeos Therapeutics Inc. (ITOS)

5.75

0.12 (2.13%)

At close: Apr 02, 2025, 3:59 PM

5.43

-5.56%

After-hours: Apr 02, 2025, 07:57 PM EDT

iTeos Therapeutics Cash Flow Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-134.41M	-112.64M	96.65M	214.52M	-38.03M	-22.45M	-18.06M
Depreciation & Amortization	1.24M	898K	803K	603K	535K	611K	505K
Stock-Based Compensation	29.94M	27.02M	21.56M	13.79M	4.29M	809K	112K
Other Working Capital	20.06M	-11.84M	-231.25M	281.93M	7.65M	-927K	-1.54M
Other Non-Cash Items	-13.59M	-7.2M	-1.72M	12K	-35K	-10K	69K
Deferred Income Tax	n/a	-3.04M	n/a	n/a	-1.26M	-1.02M	130K
Change in Working Capital	18.65M	-8.8M	-228.49M	284.21M	9.33M	-1.08M	-1.86M
Operating Cash Flow	-98.18M	-103.76M	-111.19M	513.14M	-25.18M	-23.14M	-19.1M
Capital Expenditures	-1.63M	-2.97M	-938K	-1.18M	-356K	-721K	-226K
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-520.8M	-290.54M	-445M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	391.31M	366.26M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-25K	-99K	-120K	-61K	-21K	-205K	-73K
Investing Cash Flow	-131.15M	72.66M	-446.06M	-1.24M	-377K	-926K	-299K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	-226K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.25M	1.11M	1.98M	3.66M	1.65M	167K	178K
Financial Cash Flow	122.24M	1.11M	1.98M	3.66M	340.34M	22.54M	23.51M
Net Cash Flow	-109.02M	-33.59M	-563.8M	512.38M	316.46M	-2.06M	3.24M
Free Cash Flow	-99.81M	-106.72M	-112.13M	511.96M	-25.53M	-23.87M	-19.32M